Bhagvanji Thumar

2.4k total citations
28 papers, 1.7k citations indexed

About

Bhagvanji Thumar is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Bhagvanji Thumar has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Infectious Diseases. Recurrent topics in Bhagvanji Thumar's work include Respiratory viral infections research (24 papers), Pneumonia and Respiratory Infections (10 papers) and Neonatal Respiratory Health Research (9 papers). Bhagvanji Thumar is often cited by papers focused on Respiratory viral infections research (24 papers), Pneumonia and Respiratory Infections (10 papers) and Neonatal Respiratory Health Research (9 papers). Bhagvanji Thumar collaborates with scholars based in United States, Australia and Argentina. Bhagvanji Thumar's co-authors include Ruth A. Karron, Brian R. Murphy, Peter L. Collins, Robert B. Belshe, Peter F. Wright, Stephen S. Whitehead, Valerie B. Randolph, Fernando P. Polack, Douglas C. Powers and Elizabeth Schappell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

Bhagvanji Thumar

28 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhagvanji Thumar United States 20 1.4k 812 429 255 236 28 1.7k
Valerie B. Randolph United States 13 1.2k 0.8× 830 1.0× 364 0.8× 135 0.5× 323 1.4× 18 1.6k
A. H. Brandenburg Netherlands 21 696 0.5× 614 0.8× 284 0.7× 148 0.6× 66 0.3× 33 1.3k
Vasanthi Avadhanula United States 21 960 0.7× 651 0.8× 345 0.8× 248 1.0× 171 0.7× 60 1.7k
Giulia Campanini Italy 26 1.7k 1.2× 972 1.2× 114 0.3× 221 0.9× 88 0.4× 57 2.1k
Marie‐Ève Hamelin Canada 30 1.9k 1.4× 1.0k 1.3× 300 0.7× 404 1.6× 54 0.2× 69 2.3k
Matthias F. C. Beersma Netherlands 22 1.3k 0.9× 1.0k 1.2× 120 0.3× 134 0.5× 82 0.3× 44 2.1k
Gordon Meiklejohn United States 21 1.2k 0.9× 568 0.7× 238 0.6× 258 1.0× 124 0.5× 53 1.6k
V G Hemming United States 22 1.9k 1.3× 873 1.1× 779 1.8× 252 1.0× 234 1.0× 38 2.2k
Allen Izu United States 23 1.1k 0.8× 322 0.4× 117 0.3× 475 1.9× 92 0.4× 37 2.0k
Daryl M. Lamson United States 15 783 0.6× 569 0.7× 187 0.4× 141 0.6× 41 0.2× 38 1.2k

Countries citing papers authored by Bhagvanji Thumar

Since Specialization
Citations

This map shows the geographic impact of Bhagvanji Thumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhagvanji Thumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhagvanji Thumar more than expected).

Fields of papers citing papers by Bhagvanji Thumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhagvanji Thumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhagvanji Thumar. The network helps show where Bhagvanji Thumar may publish in the future.

Co-authorship network of co-authors of Bhagvanji Thumar

This figure shows the co-authorship network connecting the top 25 collaborators of Bhagvanji Thumar. A scholar is included among the top collaborators of Bhagvanji Thumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhagvanji Thumar. Bhagvanji Thumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cunningham, Coleen K., Ruth A. Karron, Petronella Muresan, et al.. (2019). Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated. Open Forum Infectious Diseases. 6(6). ofz212–ofz212. 12 indexed citations
2.
Atwell, Jessica E., Bhagvanji Thumar, Maria A. Formica, et al.. (2019). Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea. The Pediatric Infectious Disease Journal. 38(9). e199–e202. 7 indexed citations
3.
McFarland, Elizabeth J., Ruth A. Karron, Petronella Muresan, et al.. (2018). Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children. The Journal of Infectious Diseases. 217(9). 1347–1355. 46 indexed citations
4.
Atwell, Jessica E., Bhagvanji Thumar, Leanne J. Robinson, et al.. (2015). Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea. The Journal of Infectious Diseases. 213(3). 423–431. 31 indexed citations
5.
Driscoll, Amanda J., Ruth A. Karron, Niranjan Bhat, et al.. (2014). Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens. Journal of Microbiological Methods. 107. 222–226. 21 indexed citations
6.
Seo, Sachiko, Hu Xie, Ruth A. Karron, et al.. (2014). Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes. Bone Marrow Transplantation. 49(9). 1205–1211. 4 indexed citations
7.
Karron, Ruth A., Bhagvanji Thumar, Elizabeth Schappell, Ursula J. Buchholz, & Peter L. Collins. (2013). Attenuation of Live Respiratory Syncytial Virus Vaccines Is Associated With Reductions in Levels of Nasal Cytokines. The Journal of Infectious Diseases. 207(11). 1773–1779. 9 indexed citations
8.
Talaat, Kawsar R., Ruth A. Karron, Catherine J. Luke, et al.. (2012). An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza and Other Respiratory Viruses. 7(1). 66–73. 34 indexed citations
9.
Karron, Ruth A., Bhagvanji Thumar, Sonja R. Surman, et al.. (2011). The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young Children. The Pediatric Infectious Disease Journal. 30(10). e186–e191. 12 indexed citations
10.
Talaat, Kawsar R., Ruth A. Karron, Catherine J. Luke, et al.. (2011). An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine. 29(17). 3144–3148. 34 indexed citations
11.
Karron, Ruth A., Bhagvanji Thumar, Elizabeth Schappell, et al.. (2011). Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children. Vaccine. 30(26). 3975–3981. 39 indexed citations
12.
Karron, Ruth A., Kawsar R. Talaat, Catherine J. Luke, et al.. (2009). Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine. 27(36). 4953–4960. 95 indexed citations
13.
Karron, Ruth A., Karen Callahan, Catherine J. Luke, et al.. (2009). A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults. The Journal of Infectious Diseases. 199(5). 711–716. 59 indexed citations
14.
O’Brien, Katherine L., Bhagvanji Thumar, Jana Shaw, et al.. (2008). Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus. The Journal of Infectious Diseases. 198(7). 1007–1015. 70 indexed citations
15.
Eick, Angelia A., Ruth A. Karron, Jana Shaw, et al.. (2008). The Role of Neutralizing Antibodies in Protection of American Indian Infants Against Respiratory Syncytial Virus Disease. The Pediatric Infectious Disease Journal. 27(3). 207–212. 53 indexed citations
16.
Melendi, Guillermina A., Scott J. Hoffman, Ruth A. Karron, et al.. (2006). C5 Modulates Airway Hyperreactivity and Pulmonary Eosinophilia during Enhanced Respiratory Syncytial Virus Disease by Decreasing C3a Receptor Expression. Journal of Virology. 81(2). 991–999. 24 indexed citations
17.
Karron, Ruth A., Peter F. Wright, Robert B. Belshe, et al.. (2005). Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants. The Journal of Infectious Diseases. 191(7). 1093–1104. 206 indexed citations
18.
Laham, Federico R., Víctor Israele, Javier M. Casellas, et al.. (2004). Differential Production of Inflammatory Cytokines in Primary Infection with Human Metapneumovirus and with Other Common Respiratory Viruses of Infancy. The Journal of Infectious Diseases. 189(11). 2047–2056. 124 indexed citations
19.
Durbin, Anna P., Ruth A. Karron, Wellington Sun, et al.. (2001). Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.. American Journal of Tropical Medicine and Hygiene. 65(5). 405–413. 233 indexed citations
20.
Wright, Peter F., Ruth A. Karron, Robert B. Belshe, et al.. (2000). Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy. The Journal of Infectious Diseases. 182(5). 1331–1342. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026